Harry Skip Kiil - 19 Feb 2026 Form 4 Insider Report for Medtronic plc (MDT)

Role
EVP & President Cardiovascular
Signature
/s/ Patricia Walesiewicz, attorney-in-fact
Issuer symbol
MDT
Transactions as of
19 Feb 2026
Net transactions value
-$507,705
Form type
4
Filing time
26 Feb 2026, 17:48:47 UTC
Previous filing
09 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KIIL HARRY SKIP EVP & President Cardiovascular 710 MEDTRONIC PARKWAY, MINNEAPOLIS /s/ Patricia Walesiewicz, attorney-in-fact 26 Feb 2026 0001708062

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Options Exercise $2,845,269 +30,568 +89% $93.08 64,984 19 Feb 2026 Direct F1
transaction MDT Ordinary Shares Options Exercise $1,748,442 +19,923 +31% $87.76 84,907 19 Feb 2026 Direct
transaction MDT Ordinary Shares Options Exercise $30,800 +385 +0.45% $80.00 85,292 19 Feb 2026 Direct
transaction MDT Ordinary Shares Sale $161,273 -1,648 -1.9% $97.86 83,644 19 Feb 2026 Direct
transaction MDT Ordinary Shares Sale $2,985,375 -30,568 -37% $97.66 53,076 19 Feb 2026 Direct F2
transaction MDT Ordinary Shares Sale $1,882,561 -19,255 -36% $97.77 33,821 19 Feb 2026 Direct
transaction MDT Ordinary Shares Sale $65,347 -668 -2% $97.82 33,153 19 Feb 2026 Direct
transaction MDT Ordinary Shares Sale $37,661 -385 -1.2% $97.82 32,768 19 Feb 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDT Stock Option (Right to Buy) Options Exercise $0 -30,568 -72% $0.000000 11,606 19 Feb 2026 Ordinary Shares 30,568 $93.08 Direct
transaction MDT Stock Option (Right to Buy) Options Exercise $0 -19,923 -51% $0.000000 18,926 19 Feb 2026 Ordinary Shares 19,923 $87.76 Direct
transaction MDT Stock Option (Right to Buy) Options Exercise $0 -385 -25% $0.000000 1,155 19 Feb 2026 Ordinary Shares 385 $80.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 239 shares acquired through dividend reinvestment since the last report filed by the reporting person.
F2 The price reported is a weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $97.60 to $97.775. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.